Becton, Dickinson and Company (NYSE:BDX) Stock Holdings Increased by Community Financial Services Group LLC

Community Financial Services Group LLC lifted its holdings in Becton, Dickinson and Company (NYSE:BDX) by 20.1% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,587 shares of the medical instruments supplier’s stock after purchasing an additional 266 shares during the quarter. Community Financial Services Group LLC’s holdings in Becton, Dickinson and Company were worth $360,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently modified their holdings of BDX. CWM LLC raised its position in shares of Becton, Dickinson and Company by 0.6% during the 3rd quarter. CWM LLC now owns 8,965 shares of the medical instruments supplier’s stock worth $2,161,000 after buying an additional 57 shares in the last quarter. Sound Income Strategies LLC raised its holdings in Becton, Dickinson and Company by 35.8% during the third quarter. Sound Income Strategies LLC now owns 167 shares of the medical instruments supplier’s stock worth $40,000 after purchasing an additional 44 shares in the last quarter. Paladin Wealth LLC acquired a new stake in Becton, Dickinson and Company in the third quarter worth approximately $150,000. ORG Wealth Partners LLC bought a new position in Becton, Dickinson and Company during the 3rd quarter valued at $240,000. Finally, CX Institutional increased its position in shares of Becton, Dickinson and Company by 128.6% during the 3rd quarter. CX Institutional now owns 1,175 shares of the medical instruments supplier’s stock valued at $283,000 after purchasing an additional 661 shares during the period. Institutional investors own 86.97% of the company’s stock.

Insider Buying and Selling

In related news, EVP Roland Goette sold 4,483 shares of the stock in a transaction on Friday, December 6th. The stock was sold at an average price of $221.01, for a total transaction of $990,787.83. Following the completion of the sale, the executive vice president now directly owns 24,345 shares in the company, valued at approximately $5,380,488.45. This trade represents a 15.55 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP David Shan sold 500 shares of Becton, Dickinson and Company stock in a transaction on Tuesday, January 21st. The shares were sold at an average price of $240.00, for a total value of $120,000.00. Following the sale, the executive vice president now directly owns 5,741 shares of the company’s stock, valued at approximately $1,377,840. The trade was a 8.01 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 9,844 shares of company stock valued at $2,210,716. Corporate insiders own 0.36% of the company’s stock.

Wall Street Analyst Weigh In

BDX has been the subject of several research reports. StockNews.com cut Becton, Dickinson and Company from a “buy” rating to a “hold” rating in a research note on Wednesday, December 18th. Piper Sandler lifted their price objective on shares of Becton, Dickinson and Company from $275.00 to $280.00 and gave the stock an “overweight” rating in a research note on Tuesday, January 28th. One analyst has rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $283.00.

Becton, Dickinson and Company Price Performance

NYSE BDX opened at $229.50 on Wednesday. Becton, Dickinson and Company has a 1 year low of $218.75 and a 1 year high of $251.99. The stock’s 50-day moving average price is $232.20 and its two-hundred day moving average price is $233.99. The company has a market cap of $66.56 billion, a PE ratio of 38.12, a PEG ratio of 1.65 and a beta of 0.40. The company has a current ratio of 1.13, a quick ratio of 0.74 and a debt-to-equity ratio of 0.69.

Becton, Dickinson and Company (NYSE:BDX) last issued its quarterly earnings results on Wednesday, February 5th. The medical instruments supplier reported $3.43 EPS for the quarter, beating the consensus estimate of $3.00 by $0.43. Becton, Dickinson and Company had a net margin of 8.47% and a return on equity of 15.74%. On average, analysts predict that Becton, Dickinson and Company will post 14.41 EPS for the current year.

Becton, Dickinson and Company announced that its Board of Directors has initiated a stock buyback plan on Tuesday, January 28th that permits the company to buyback 10,000,000 shares. This buyback authorization permits the medical instruments supplier to repurchase shares of its stock through open market purchases. Stock buyback plans are often an indication that the company’s board of directors believes its shares are undervalued.

Becton, Dickinson and Company Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 10th will be given a dividend of $1.04 per share. This represents a $4.16 annualized dividend and a yield of 1.81%. The ex-dividend date of this dividend is Monday, March 10th. Becton, Dickinson and Company’s payout ratio is 69.10%.

About Becton, Dickinson and Company

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional.